Current Technology Corporation Reports UK Subsidiary Commences Operations

VANCOUVER, British Columbia, Dec. 19 /PRNewswire-FirstCall/ -- The following was issued today by Robert Kramer, Director, Current Technology Corporation :

Current Technology (the “Company”) reports its wholly owned subsidiary Current Technology (UK) Ltd., (the “Subsidiary”) has commenced operations in London, England. As reported on October 4, 2005, when the Company appointed Anchorage Capital Partners Limited (“ACP”) as Corporate Finance and Investment Advisor:

1. the Company is granting the Subsidiary the exclusive right to market and sell its proprietary TrichoGenesis technology in Europe and the Middle East;

2. ACP to raise up to 3 million Pounds Sterling of private equity from institutional investors and/or high net worth individuals located outside the United States on a best efforts basis (the “Financing”);

3. post-Financing, Current Technology to maintain a majority ownership position in the Subsidiary; and

4. subject to market conditions and corporate performance, the Subsidiary to seek a listing on the London Stock Exchange’s AIM market. (“The most successful growth market in the world,” according to AIM literature.)

The Subsidiary’s Board of Directors is initially comprised of three people: Thomas R. Byrne (ACP Managing Director), Robert Kramer (Company CEO), and Herman Kullar. Mr. Kullar is the Chief Financial Officer and Secretary of the Subsidiary; Mr. Kramer is CEO. Both the Director of Sales and Director of Marketing have been identified, but are not yet revealed as they are presently employed elsewhere.

The Subsidiary’s Business Plan is virtually complete and formal meetings with prospective investors will commence in January 2006. While the Financing is in process, Mr. Kullar will introduce the patented TrichoGenesis platform to spas/salons/health clubs in the UK and other areas in Europe and the Middle East.

“I am both pleased and extremely excited to be part of this tremendous opportunity,” states Subsidiary CFO Herman Kullar. “I believe our revenue sharing model will allow us to grow at an aggressive pace and I am looking forward to help introduce the TrichoGenesis platform to the UK, Europe and Middle East markets.”

“ACP is very keen to begin marketing the private equity capital raise, and will do so aggressively in the beginning of January 2006,” states ACP Managing Director Thomas R. Byrne. “We believe the Company’s strategy is sound and the management on board is extremely capable, making for a winning combination. In the past two months we have seen a number of opportunities present themselves to this new subsidiary, which we are eager to exploit.”

ABOUT MR. HERMAN KULLAR

Mr. Kullar has an extensive background as a Financial Officer in small technology driven companies, where it was also necessary to act as a business development coordinator. Mr. Kullar’s broad background includes eight (8) years (1995-2003) as Financial & Commercial Director of Peter Gabriel, Ltd. / Real World Group, the music publishing and recording company. He was responsible for creating, coordinating and implementing the Group’s financial strategy; daily operations of the accounting function; prepared budgets; dealt with all aspects of taxation, insurance, health/safety and monitored the Chairman’s personal financial affairs. Mr. Kullar took direct control for the global marketing of a new multimedia product where he generated 2 million plus Pounds Sterling in revenue in the first nine months and a total of 6 million Pounds Sterling over four years, turning the company into profitability. Mr. Kullar’s CV also includes CFO of Very Small Technologies Inc., a MEMS/Nano- technology company based in New York and as Managing Director and Chief Accountant for General Instrument Corp; Semitron Industries, Ltd., located in the U.K. (1990-1995).

ABOUT MR. THOMAS R. BYRNE

Mr. Thomas R. Byrne, ACP co-founder and Managing Director, will lead the corporate financing transaction. Mr. Byrne has been directly involved in structuring, advising and distributing global private equity deals over his 24 year career in the financial markets. His private equity background has brought him particular experience in Medical Technology, Biotechnology and Nano-Technology. He focuses on developing innovative financing strategies which fit strategically to each engagement. For example, he developed a leasing strategy for a gaming company which raised more than 50 million Pounds Sterling, allowing it to manufacture and place its gaming equipment without giving up significant equity. The gaming company recently completed a very successful IPO on the London Stock Exchange. He is presently working on a 15 million Pounds Sterling private equity raise for a new premium class only trans-Atlantic airline. Mr. Byrne has actively participated in a number of private equity deals over the past eight years, which successfully raised over US$250 million.

ABOUT CURRENT TECHNOLOGY CORPORATION

Current Technology Corporation remains committed to developing its non- invasive pulsed electro-stimulation technology. This technology has enabled the company to develop two separate and distinct products emanating from the TrichoGenesis platform, thus far, that offer help for those concerned with their hair: ElectroTrichoGenesis (ETG) and CosmeticTrichoGenesis (CTG). Current Technology holds patents throughout the world and has spent over US $15 million in research and development of its TrichoGenesis platform and systems. The patents encompass the technology, methodology and design of the Company’s products.

Current Technology Corporation

CONTACT: CORPORATE: Robert Kramer of Current Technology Corporation,+1-800-661-4247, +1-604-684-2727, or rkramer@current-technology.com; orINVESTOR RELATIONS: Richard Hannon of Polestar Communications,+1-866-858-4100, for Current Technology Corporation